Financials

  • Market Capitalization 7.96 B
  • Employee 315
  • Founded 2018
  • CEO N/A
  • Website www.immunovant.com
  • Headquarter Delaware, United States
  • FIGI BBG00P5MC0Q8
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-8.97
Índice preço/fluxo de caixa

Related tickers

#NomePreços24h %7d %1M %1A %Capitalização de mercadoÚltimos 7 dias
1018
APGE
Apogee Therapeutics, Inc. - Common Stock
133.96 USD+0.10%+0.28%+49.41%+149.97%8.29 B USD
1030
PCVX
Vaxcyte, Inc. - Common Stock
56.20 USD-1.46%-7.37%+17.80%+32.86%8.12 B USD
1048
KNSA
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares
62.01 USD+1.76%-7.85%+19.83%+56.41%7.75 B USD
1075
RYTM
Rhythm Pharmaceuticals, Inc. - Common Stock
109.83 USD+2.18%-4.05%+18.10%-0.44%7.53 B USD

Notícias